Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance. (Q39093352)
Jump to navigation
Jump to search
scientific article published on September 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance. |
scientific article published on September 2017 |
Statements
Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance (English)
1 reference